Section 7 of 8
Learning points
Huy H Do, Balasubramanian Krishnamurthy, Vivian Grill, Christopher Leow, and Hanh H Nguyen · about 1 minutes
- Osteosclerosis is an uncommon finding but has significant clinical implications as it is frequently secondary to several serious conditions.
- Systemic mastocytosis-related bone disease is rare and should be considered in cases with atopic symptoms and unexplained osteoporosis/osteosclerosis.
- The mechanism underlying mastocytosis-related bone disease remains poorly understood but is thought to be related to inflammatory mediators secreted by mast cells, resulting in an imbalance in osteoblastic and osteoclastic activity.
- Treatment options for SM-related osteosclerosis are limited, while antiresorptive therapy has demonstrated efficacy in SM-associated osteoporosis.
- Further studies are required to better understand the underlying mechanism and clinical trajectory of SM-related osteosclerosis.